Key Highlights
- LTIMindtree secured a $100 million multi-year strategic agreement with a European MedTech firm.
- The contract duration spans seven years covering product development and support services.
- The deal focuses on hearing instruments, wearable devices, and mobile applications.
- LTIMindtree will leverage its iNXT digital transformation platform for delivery.
- The company will also manage compliance and regulatory frameworks for MedTech operations.
LTIMindtree has announced the signing of a multi-year strategic agreement valued at $100 million with a Europe-based medical technology company specializing in advanced hearing solutions. The partnership is aimed at strengthening product innovation, digital capabilities, and long-term technology support across the client’s flagship hearing device portfolio.
Under the seven-year engagement, LTIMindtree will provide end-to-end product development and lifecycle support for the MedTech company’s primary hearing instrument brands as well as its private-label offerings. The scope includes development and maintenance of wearable hearing devices, software platforms used by hearing care professionals for device configuration, and mobile applications that enable users to manage and control hearing instruments.
The company plans to deploy its iNXT platform, a cross-industry digital transformation and innovation framework designed to help enterprises integrate physical products with digital ecosystems. Through this platform, LTIMindtree aims to enhance product performance, accelerate innovation cycles, and improve user experience across connected healthcare devices.
In addition to engineering and software development, LTIMindtree will support the client in navigating complex regulatory and compliance requirements associated with the global MedTech industry. This includes ensuring adherence to healthcare standards and evolving regulatory frameworks across multiple markets.
LTIMindtree, part of the Larsen & Toubro Group, continues to expand its presence in the healthcare technology segment as enterprises increasingly invest in AI-led digital transformation and connected medical devices. The company operates across integrated operations, business AI, and transformation services, supporting enterprises in adopting next-generation technology solutions.
The latest agreement highlights growing demand for specialized engineering and digital capabilities in the global medical technology sector, particularly in areas such as wearable healthcare devices and patient-centric digital applications.